Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sanofi Improperly Listed Lantus Patent In FDA's Orange Book, Appeals Court Finds
Feb 16 2020
•
By
Brenda Sandburg
Appeals court revives antitrust claims against Sanofi for improper patent listing in FDA's Orange Book
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legal & IP
More from Pink Sheet